Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience) - Image 1

£87.80

CRC Press Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

Name: Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
Brand: CRC Press
Price: 85.0 GBP
Availability: InStock

22 black & white illustrations

Geriatrics

Price History & Forecast

Last 44 days • 44 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 44 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £85 (29 days, 65.9%)

Price range: £85 - £88

Price levels: 2 different prices over 44 days

Description

In recent years, a tremendous amount of effort has been focused on better understanding the fundamentals of Alzheimer’s disease (AD) to facilitate early and accurate diagnosis and appropriately targeted therapeutic treatments. Alzheimer’s Disease: Targets for New Clinical, Diagnostic, and Therapeutic Strategies provides a detailed synopsis of the current state of the art of diagnostics and therapeutics and identifies emerging technologies and molecules that show promise in the management and treatment of AD. With contributions from experts drawn from academia, clinical practice, and the biotechnology and pharmaceutical industries, the book explores: The basis of AD and the role of Aβ oligomers in development of disease Existing and emerging in vitro biomarker-based methodologies for the diagnosis of AD, focusing on genetic, biochemical, and conformational strategies In vivo imaging diagnostic approaches Evolving diagnostic criteria, health regulatory guidelines, biomarkers in clinical trials, and available and emerging therapies Recent progress in small-molecule disease-modifier drug discovery efforts for AD, specifically in the areas of Aβ, tau, and emerging neuroprotective/neurorepair approaches How a case study of AD raises issues regarding clinical and pathologic criteria, risk factors, and the amyloid hypothesis The molecular conformational factors that govern the pathogenicity of aggregating proteins, and how these factors could represent new targets for disease-modifying therapies The latest epidemiological, pathological, biochemical, and behavioral studies that may shed some light on the risk of developing AD and similar dementias after traumatic brain injury Examining current hypotheses and suggesting possible new approaches to therapeutic clinical applications, this volume paves the way for a robust pipeline of therapeutics to combat not only AD, but a whole host of other neurodegenerative diseases.

Product Specifications

Brand: CRC Press
Model: 22 black & white illustrations
Format: hardcover
ASIN: 1439827087
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Geriatrics
Domain: Amazon UK
Release Date: 26 April 2012
Listed Since: 16 August 2010

Barcode

No barcode data available

CRC Press Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Multi-Factorial Approach as a Therapeutic Strategy for the Management of Alzheimer’s Disease

A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment

Molecular Targets in Protein Misfolding and Neurodegenerative Disease: Focus on Tau, Alzheimer's Disease, and Other Tauopathies

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

Computational and Experimental Studies in Alzheimer's Disease

Molecular Biology of Alzheimer's Disease: Genes and Mechanisms Involved in Amyloid Generation

Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta: 38 (Subcellular Biochemistry)

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (Enzyme Inhibitors)

Neuroprotection in Alzheimer's Disease

Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Neuropsychological Tools for Dementia: Differential Diagnosis and Treatment

Alzheimer's Disease Research Guide: Animal Models for Understanding Mechanisms and Medications

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Current Hypotheses and Research Milestones in Alzheimer's Disease

Neurochemical Aspects of Alzheimer's Disease: Risk Factors, Pathogenesis, Biomarkers, and Potential Treatment Strategies

Biomarkers for Early Diagnosis of Alzheimer's Disease

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Research Progress in Alzheimer's Disease And Dementia: 1: v. 1: Volume 1

The Biology of Alzheimer Disease (Cold Spring Harbor Perspectives in Medicine)